ICON plc (NASDAQ - ICLR)
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.
Headquarters: Dublin, Ireland
Financial Information: ICON's revenue for FY ending 31 December 2010 was US$900 million. ICON trades on the NASDAQ and Irish (ISEQ) exchanges.
ICON currently has over 7,800 employees in 78 offices in 39 countries.
Products and Services
ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new treatments to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
Phase I-IV Clinical Trials
Late Phase & Outcomes Research
Central Laboratory Services
North America, South America, Europe, Africa, Middle East, Asia, Pacific Rim
Central Laboratory Services, Clinical Pharmacology, Clinical Trial Design, Clinical Trial Monitoring, Data Management, Health Economics, Imaging, Patient Compliance, Pharmacokinetic/Pharmacodynamic Modeling, Regulatory Affairs/Regulatory Strategy
South County Business Park, Leopardstown
Phone : 012912000
Fax : 012912700
Internet : www.iconplc.com
Email : email@example.com
Contact Person : Niamh Murphy